A Phase I Study of CFT8919 in Patients With Advanced NSCLC

Clinical trial NCT06641609 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06641609
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer With EGFR Mutation

Start date: 2024-12-13
Primary completion: 2025-12-09
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.